Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 06:24 AM. | Search:

» StockRants Stock Forum » Public Stock Forums » US Stock Picks » FDA Approval Dates



Reply
 
Thread Tools Search this Thread
Old 12-12-2010, 03:04 PM   Nav to Top  #21
kabilius
VIP Trader
 
kabilius's Avatar
 
Join Date: Jun 2009
Location: LA
Posts: 159
Favorites: KERX, OREX, SUPG
Rep Power: 165
Reputation: 786
kabilius is a splendid one to beholdkabilius is a splendid one to beholdkabilius is a splendid one to beholdkabilius is a splendid one to beholdkabilius is a splendid one to beholdkabilius is a splendid one to beholdkabilius is a splendid one to behold
Thread Starter
Default

Hi all,

Here is the latest FDA update:

2010-12-31 OraSure Technology (OSUR) FDA Decision
2011-02-25 Protalix BioTherapeutics (PLX) FDA Decision
2011-03-31 Cell TheraPeutics (CTIC) FDA Decision
2011-04-29 Spectrum Pharmaceutical (SPPI) FDA Decision
2011-06-30 Affyax, Inc (AFFY) FDA filing
2011-09-30 Gilead Sciences (GILD) FDA Decision
2011-12-31 Cornerstone Therapeutics (CRTX) FDA Decision
2011-06-30 Vivus, Inc (VVUS) FDA filing
2011-06-30 Alexza Pharma (ALXA) FDA Decision
2011-06-30 Onyx Pharmaceuticals (ONXX) FDA filing
2011-01-31 Orexigen Therapeutics (OREX) FDA Decision
2011-06-30 Optimer Pharma (OPTR) Potential FDA Filing
2011-06-30 Teva Pharmaceutical (TEVA) FDA Decision
2010-12-30 pSivida Corp (PSDV) FDA Decision
2011-03-26 Bristol Myers (BMY) FDA Advisory Panel


Remember, some of these dates are just estimates, and the dates may be updated as time goes by. And of course, do your due diligence before investing!

kab
__________________
Rule #1 of a stock investor - Say no to greed
kabilius is offline   1 thumbs up / 0 thumbs down. Rate this post Yes | No Reply With Quote
Old 12-12-2010, 09:33 PM   Nav to Top  #22
Saintjames
UberTrader
 
Saintjames's Avatar
 
Join Date: Apr 2009
Location: Victoria
Posts: 248
Favorites: TSE:COS | TSE:CPG | TSE:LRE
Rep Power: 183
Reputation: 1115
Saintjames has much to be proud ofSaintjames has much to be proud ofSaintjames has much to be proud ofSaintjames has much to be proud ofSaintjames has much to be proud ofSaintjames has much to be proud ofSaintjames has much to be proud ofSaintjames has much to be proud ofSaintjames has much to be proud of
Did I help?
Default

Big thumbs up and thanks for sharing Kabilius
Saintjames is offline   Rate this post Yes | No Reply With Quote
Old 02-01-2011, 05:07 AM   Nav to Top  #23
Saintjames
UberTrader
 
Saintjames's Avatar
 
Join Date: Apr 2009
Location: Victoria
Posts: 248
Favorites: TSE:COS | TSE:CPG | TSE:LRE
Rep Power: 183
Reputation: 1115
Saintjames has much to be proud ofSaintjames has much to be proud ofSaintjames has much to be proud ofSaintjames has much to be proud ofSaintjames has much to be proud ofSaintjames has much to be proud ofSaintjames has much to be proud ofSaintjames has much to be proud ofSaintjames has much to be proud of
Did I help?
Default FDA APPROVAL DATES FOR 2011

FDA APPROVAL DATES FOR 2011

Mannkind (MNKD)
Drug/indication: Afrezza for diabetes
Approval decision date: Dec. 29, 2010
This is the second review cycle for Afrezza, a small, inhaled insulin device for diabetes.

Alimera Sciences (ALIM) and pSivida (PSDV)
Drug/indication: Iluvien for diabetic macular edema
Approval decision date: Dec. 30, 2010

AztraZeneca (AZN)
Drug/indication: Zictifa for medullary thyroid cancer
Approval decision date: Jan. 7, 2011
An FDA advisory panel on Dec. 2 gave conditional support to the approval of Zictifa, also recommending that a post-approval study be conducted to determine if a lower dose could reduce side effects while maintaining efficacy.

Clinical Data (CLDA)
Drug/indication: Vilazodone for major depressive disorder
Approval decision date: Jan. 22, 2011

Orexigen Therapeutics (OREX)
Drug/indication: Contrave for obesity
Approval decision date: Jan. 31, 2011
An FDA advisory panel held Dec. 7 voted 13-7 to recommend Contrave's approval.

Bristol-Myers Squibb (BMY)
Drug/indication: Yervoy (ipilimumab) for melanoma
FDA advisory panel meeting: Feb. 9, 2011
Approval decision date: March 26, 2011
Both the FDA advisory panel meeting and the FDA's approval decision date for Yervoy were pushed back from December after Bristol submitted additional clinical data. Bristol is seeking initial approval for ipilimumab for patients who have previously received treatment for melanoma.

Pfizer (PFE_) and Protalix Biotherapeutics (PLX)
Drug/indication: Uplyso for Gaucher's disease
Approval decision date: Feb. 25, 2011

Salix Pharmaceuticals (SLXP)
Drug/indication: Xiafaxan for irritable bowel syndrome
Approval decision date: March 7, 2011
Xiafaxan is already approved for travelers' diarrhea and hepatic encephalopathy.

Human Genome Sciences
(HGSI)
Drug/indication: Benlysta for lupus
Approval decision date: March 10, 2011
If approved, Benlysta would be the first new drug for lupus patients in 50 years. GlaxoSmithKline(GSK_) will co-market Benlysta. The FDA's approval decision date was pushed back three months from Dec. 9, 2010.

Dendreon (DNDN)
Drug/indication: Provenge for prostate cancer (manufacturing expansion)
Approval decision date: March 2011
Dendreon is seeking FDA approval to expand Provenge manufacturing capacity at its New Jersey facility. Two additional Provenge plants are under construction outside Atlanta and in Orange Country, Calif. that are expected to come on line in the middle of the year.

InterMune (ITMN)
Drug/indication: Esbriet for idiopathic pulmonary fibrosis
Approval decision date: First quarter 2011 (estimated)
Intermune is seeking European approval for Esbriet after the FDA rejected the drug in 2010.

Cell Therapeutics (CTIC)
Drug/indication: Pixantrone for aggressive non-Hodgkin's lymphoma
Approval decision date: First quarter 2011
Cell Therapeutics filed an appeal with FDA contesting the agency's April 2010 rejection of pixantrone.

Forest Laboratories (FRX)
Drug/indication: Daxas for chronic obstructive pulmonary disorder
Approval decision date: First quarter 2011
This is the second FDA review cycle for Daxas.

Xenoport (XNPT) and GlaxoSmithKline
Drug/indication: Horizant for restless leg syndrome
Approval decision date: April 6, 2011
This is the second FDA review cycle for Horizant. The original new drug application was filed to FDA in January 2009.

Spectrum Pharmaceuticals (SPPI)
Drug/indication: Fusilev for colon cancer
Approval decision date: April 29, 2011
This is the second review for Fusilev in colon cancer. The drug is already approved as a treatment for a form of bone cancer.

Adventrx Pharmaceuticals (ANX)
Drug/indication: ANX-530 for non-small cell lung cancer
Approval decision date: May 3, 2011 (estimated, based on Adventrx's Nov. 3, 2010 filing and assuming a six-month FDA review.)
ANX-530 is a reformulation of the generic chemotherapy drug vinorelbine. The FDA issue a refuse-to-file letter for ANX-530 in 2010.

Vertex Pharmaceuticals (VRTX)
Drug/indication: Telaprevir for Hepatitis C
Approval decision date: May 23, 2011 (estimated, based on Vertex's filing for approval on Nov. 23, 2010 and assuming six-month FDA review.)

Delcath Systems (DCTH)
Drug/indication: Hepatic ChemoSat Delivery System for liver metastases in melanoma patients
Approval decision date: June 2011 (estimated, based on expected 2010 year-end filing and a six-month FDA review.)

Seattle Genetics
(SGEN)
Drug/indication: brentuximab vedotin for Hodgkin's lymphoma
Approval decision date: Third quarter 2011 (estimated, based on the company's forecast for a first-quarter 2011 approval filing.)

MELA Sciences (MELA)
Device/indication: MELAFind for diagnosis of melanoma
Approval decision date: Unknown
FDA rejected MELAFind in March 2010 but an FDA advisory panel in November narrowly recommended the device's approval over the FDA's objection. The FDA has not said when it will issue another approval decision for MELAFind.

Additional drugs with potential regulatory milestones in 2011:

Osiris Therapeutics (OSIR)
Drug/indication: Prochymal for graft-versus-host disease
Status: Prochymal phase III studies failed but Osiris says it plans to meet with FDA "early next year" to determine if Prochymal can still be filed for approval.

Transcept Pharmaceuticals (TSPT)
Drug/indication: Intermezzo for insomnia
Status: Transcept intends to resubmit Intermezzo to FDA in first quarter 2011 following a complete response letter in October 2009.

Genzyme (GENZ_) and Isis Pharmaceuticals (ISIS)
Drug/indication: mipomersen for severe hypercholesterolemia
Status: Genzyme is expected to file for mipomersen approval in the first half 2011.

MAP Pharmaceuticals (MAPP)
Drug/indication: Levadex for migraines
Status: MAP intends to file for Levadex approval in the first half of 2011.

Arena Pharmaceuticals (ARNA)
Drug/indication: lorcaserin for obesity
Status: FDA rejected lorcaserin in October. Arena has not yet disclosed a timetable for resubmitting lorcaserin to FDA.

Vivus (VVUS)
Drug/indication: Qnexa for obesity
Status: FDA rejected Qnexa in October. Vivus intends to resubmit Qnexa to FDA before the end of 2010.

Amylin Pharmaceuticals (AMLN), Alkermes(ALKS) and Eli Lilly(LLY)
Drug/indication: Bydureon for diabetes
Status: Additional clinical work required by FDA after October rejection is ongoing. Resubmission expected by end of 2011.

Alexza Pharmaceuticals (ALXA)
Drug/indication: AZ-004 for agitation in patients with schizophrenia or bipolar disorder
Status: FDA rejected Alexza in October; Alexza still determining a resubmission strategy.
Saintjames is offline   1 thumbs up / 0 thumbs down. Rate this post Yes | No Reply With Quote
Old 02-05-2012, 12:18 AM   Nav to Top  #24
kcdclan
Junior Trader
 
kcdclan's Avatar
 
Join Date: Feb 2012
Location: florida
Posts: 2
Favorites: S FB ZNGA
Rep Power: 95
Reputation: 10
kcdclan is on a distinguished road
Default

Threshold Pharmaceutical... (THLD)
On TH-302 just got a huge boost , fda has not approved yet
kcdclan is offline   Rate this post Yes | No Reply With Quote
Old 05-02-2013, 03:53 PM   Nav to Top  #25
charliee
Trader
 
charliee's Avatar
 
Join Date: Apr 2013
Location: Irvine
Posts: 46
Favorites: BUD, WOOF, BOOM
Rep Power: 81
Reputation: 21
charliee is on a distinguished road
Default

Hello,
I am new here, but very happy to be a part of this discussion board. A very informative site for stocks and related subject.
charliee is offline   Rate this post Yes | No Reply With Quote
Old 05-05-2013, 10:55 AM   Nav to Top  #26
Jediguy
Junior Trader
 
Jediguy's Avatar
 
Join Date: May 2013
Location: Ames
Posts: 1
Favorites: AMD, MSFT, ZNGA
Rep Power: 80
Reputation: 10
Jediguy is on a distinguished road
Default

I too am new and just wanted to say that this thread is great. I just wish it was kept up to date.
Jediguy is offline   Rate this post Yes | No Reply With Quote
Old 03-08-2017, 07:17 AM   Nav to Top  #27
nic
Junior Trader
 
nic's Avatar
 
Join Date: Mar 2017
Location: indore
Posts: 1
Favorites: apple, facebook, alibaba
Rep Power: 33
Reputation: 10
nic is on a distinguished road
Default

good information friend
nic is offline   Rate this post Yes | No Reply With Quote
Old 06-20-2019, 07:33 AM   Nav to Top  #28
scarlettsmith694
Trader
 
scarlettsmith694's Avatar
 
Join Date: May 2019
Location: Sydney
Posts: 35
Favorites: ASX:AWC, ASX:APA, ASX:NAN
Rep Power: 7
Reputation: 11
scarlettsmith694 is on a distinguished road
Default

Bitcoin price is doubled from previous price and it is rapidly rising after disastrous 2018 when cryptocurrency losses its more than 60% of its value. Also, the bitcoin price swinging over the last couple week.
scarlettsmith694 is offline   Rate this post Yes | No Reply With Quote
Reply

Similar Threads
Thread Thread Starter Forum Replies Last Post
Short: Does EU approval of a drug significantly FDA approval chances? Bnmakr1 US Stock Picks 1 08-03-2009 03:49 PM
Spec: FDA decision dates - Medical Devices kabilius US Stock Picks 0 08-01-2009 01:50 PM
Watch: Food / drug approval decision dates kabilius US Stock Picks 29 07-14-2009 10:13 PM
fda approval dates timlonab70 Traders Lounge 2 06-09-2009 01:49 AM
What's with these FDA dates being on Sundays and holidays? Billy Traders Lounge 3 05-31-2009 05:11 PM


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On